Bluebird Bio's total assets for Q1 2025 were $295.96M, a decrease of -35.69% from the previous quarter. BLUE total liabilities were $353.82M for the fiscal quarter, a -28.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.